ArticleBMC infectious diseases2025

Performance evaluation of alternative bacteriological measures of response to MDR/RR-TB therapy during the initial 16 weeks of treatment.

Willy Ssengooba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.